User profiles for Makuza Jean Damascene

Jean Damascene Makuza

PhD student-School of Population and Public Health, University of British Columbia
Verified email at bccdc.ca
Cited by 615

Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda

JD Makuza, S Nsanzimana, MA Muhimpundu… - Pan African Medical …, 2015 - ajol.info
Introduction: Cervical cancer prevalence in Rwanda has not been well-described. Visual
inspection with acetic acid or Lugol solution has been shown to be effective for cervical cancer …

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial

…, F Kateera, G Camus, MJ Damascene… - The lancet …, 2019 - thelancet.com
Background Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan
Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of …

Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda

JD Makuza, JOT Rwema, CK Ntihabose… - BMC infectious …, 2019 - Springer
Background The epidemiology of hepatitis B virus (HBV) infection in the general population
in Rwanda is not well known. This study examined the prevalence of HBV surface antigen (…

Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment …

…, A Murangwa, J Serumondo, JD Makuza… - The Lancet …, 2022 - thelancet.com
Background Hepatitis C virus (HCV) genotype 4 non-a/d subtypes, which frequently have
NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These …

The cascade of care for hepatitis C treatment in Rwanda: a retrospective cohort study of the 2017–2019 mass screening and treatment campaign

MP Nisingizwe, JD Makuza, NZ Janjua, N Bansback… - Viruses, 2023 - mdpi.com
Access to hepatitis C (HCV) testing and treatment is still limited globally. To address this, the
Government of Rwanda launched a voluntary mass screening and treatment campaign in …

Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program

JD Makuza, CY Liu, CK Ntihabose… - BMC infectious …, 2019 - Springer
Background The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda
are not well known; however, this information is crucial to shaping the country’s public …

[HTML][HTML] Controlling hepatitis C in Rwanda: a framework for a national response

…, J Mugabo, M Mwumvaneza, JD Makuza… - Bulletin of the World …, 2018 - ncbi.nlm.nih.gov
With the introduction of direct-acting antiviral drugs, treatment of hepatitis C is both highly
effective and tolerable. Access to treatment for patients, however, remains limited in low-and …

Predictors of mortality in a paediatric intensive care unit in Kigali, Rwanda

…, AC Karambizi, JC Kabayiza, JD Makuza… - Paediatrics and …, 2017 - Taylor & Francis
Background: The enormous burden of critical illness in resource-limited settings has led to a
growing interest in paediatric critical care in these regions. However, published data on the …

The association between HIV self-test awareness and recent HIV testing uptake in the male population in Gambia: data analysis from 2019–2020 demographic and …

P Soe, LG Johnston, JD Makuza, ME Karim - BMC Infectious Diseases, 2023 - Springer
Background The Gambian Ministry of Health is supportive of HIV self-testing (HIVST) and
HIVST initiatives are being piloted as an additional strategy to increase HIV testing for …

Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study

…, JP Gakuru, T Musafiri, S Urusaro, JD Makuza… - PloS one, 2021 - journals.plos.org
Introduction As part of the integration of refugees into Rwanda’s national hepatitis C elimination
agenda, a mass screening campaign for hepatitis B (HBV) and hepatitis C (HCV) was …